Synthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agents

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

A series of coumarin-chalcone hybrids have been synthesized and evaluated for their in vitro cytotoxicity against a panel of four human cancer cell lines and normal fibroblasts (NIH3T3). Among 21 compounds screened, three compounds (23, 25 and 26) showed IC(50) range from 3.59 to 8.12 μM. The most promising compound 26 showed around 30-fold more selectivity towards C33A (cervical carcinoma) cells over normal fibroblast NIH3T3 cells with an IC(50) value of 3.59 μM.

Knowledge Graph

Similar Paper

Synthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agents
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis and biological evaluation of novel coumarin–pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents
European Journal of Medicinal Chemistry 2013.0
Synthesis, biological evaluation and molecular docking of novel chalcone–coumarin hybrids as anticancer and antimalarial agents
European Journal of Medicinal Chemistry 2014.0
Synthesis of new conjugated coumarin–benzimidazole hybrids and their anticancer activity
Bioorganic & Medicinal Chemistry Letters 2013.0
Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action
Bioorganic & Medicinal Chemistry 2017.0
Synthesis and selective cytotoxic activity of novel hybrid chalcones against prostate cancer cells
Bioorganic & Medicinal Chemistry Letters 2012.0
Chalcone–benzoxaborole hybrids as novel anticancer agents
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and biological evaluation of novel 4,7-dihydroxycoumarin derivatives as anticancer agents
Bioorganic & Medicinal Chemistry Letters 2019.0
Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents
European Journal of Medicinal Chemistry 2014.0
Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents
European Journal of Medicinal Chemistry 2013.0